BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31039468)

  • 1. Impact of deviations in target volume delineation - Time for a new RTQA approach?
    Cox S; Cleves A; Clementel E; Miles E; Staffurth J; Gwynne S
    Radiother Oncol; 2019 Aug; 137():1-8. PubMed ID: 31039468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
    Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.
    Brade AM; Wenz F; Koppe F; Lievens Y; San Antonio B; Iscoe NA; Hossain A; Chouaki N; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):927-934. PubMed ID: 29976505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment.
    Zhong H; Men K; Wang J; van Soest J; Rosenthal D; Dekker A; Zhang Z; Xiao Y
    Front Oncol; 2019; 9():792. PubMed ID: 31497534
    [No Abstract]   [Full Text] [Related]  

  • 5. The radiotherapy quality assurance gap among phase III cancer clinical trials.
    Corrigan KL; Kry S; Howell RM; Kouzy R; Jaoude JA; Patel RR; Jhingran A; Taniguchi C; Koong AC; McAleer MF; Nitsch P; Rödel C; Fokas E; Minsky BD; Das P; Fuller CD; Ludmir EB
    Radiother Oncol; 2022 Jan; 166():51-57. PubMed ID: 34838891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
    Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
    Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
    Mir R; Kelly SM; Xiao Y; Moore A; Clark CH; Clementel E; Corning C; Ebert M; Hoskin P; Hurkmans CW; Ishikura S; Kristensen I; Kry SF; Lehmann J; Michalski JM; Monti AF; Nakamura M; Thompson K; Yang H; Zubizarreta E; Andratschke N; Miles E
    Radiother Oncol; 2020 Sep; 150():30-39. PubMed ID: 32504762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives.
    de Rojas T; Clementel E; Giralt J; Cruz O; Boterberg T; Kortmann RD; Gaze MN; Moreno L; Janssens GO;
    Eur J Cancer; 2019 Jun; 114():36-46. PubMed ID: 31035085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QA makes a clinical trial stronger: evidence-based medicine in radiation therapy.
    Weber DC; Tomsej M; Melidis C; Hurkmans CW
    Radiother Oncol; 2012 Oct; 105(1):4-8. PubMed ID: 22985777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).
    Lukovic J; Moore AJ; Lee MT; Willis D; Ahmed S; Akra M; Hortobagyi E; Kron T; Lim Joon D; Liu A; Ryan J; Thomas M; Wall K; Ward I; Wiltshire KL; O'Callaghan CJ; Wong RKS; Ringash JG; Haustermans K; Leong T
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1096-1106. PubMed ID: 37393022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.
    Dundar Y; Dodd S; Dickson R; Walley T; Haycox A; Williamson PR
    Health Technol Assess; 2006 Feb; 10(5):iii-iv, ix-145. PubMed ID: 16487455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges for Quality Assurance of Target Volume Delineation in Clinical Trials.
    Chang ATY; Tan LT; Duke S; Ng WT
    Front Oncol; 2017; 7():221. PubMed ID: 28993798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIELD
    Piazzese C; Evans E; Thomas B; Staffurth J; Gwynne S; Spezi E
    Br J Radiol; 2021 Oct; 94(1126):20210356. PubMed ID: 34289317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials.
    Ohri N; Shen X; Dicker AP; Doyle LA; Harrison AS; Showalter TN
    J Natl Cancer Inst; 2013 Mar; 105(6):387-93. PubMed ID: 23468460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial breast irradiation for early breast cancer.
    Lehman M; Hickey BE; Francis DP; See AM
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007077. PubMed ID: 24938937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Colleague Peer Review on the Radiotherapy Treatment Planning Process in the Radical Treatment of Lung Cancer.
    Rooney KP; McAleese J; Crockett C; Harney J; Eakin RL; Young VA; Dunn MA; Johnston RE; Hanna GG
    Clin Oncol (R Coll Radiol); 2015 Sep; 27(9):514-8. PubMed ID: 26150375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial.
    Gkika E; Schimek-Jasch T; Kremp S; Lenz S; Stockinger M; Schaefer-Schuler A; Mix M; Küsters A; Tosch M; Hehr T; Eschmann SM; Bultel YP; Hass P; Fleckenstein J; Thieme AH; Dieckmann K; Miederer M; Holl G; Rischke HC; Adebahr S; König J; Binder H; Grosu AL; Nestle U
    Radiother Oncol; 2021 Oct; 163():32-38. PubMed ID: 34311004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.